Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
暂无分享,去创建一个
M. J. van den Bent | B. van der Holt | P. S. Sillevis Smitt | C. Vecht | H. Hooijkaas | Herbert Hooijkaas | Bronno van der Holt | B. de Leeuw | Martin van den Bent | Charles Vecht | Setareh Shams'ili | Joost Grefkens | Bertie de Leeuw | Peter Sillevis Smitt | S. Shams’ili | J. Grefkens | Joost Grefkens | Setareh Shams’ili
[1] H. Greenberg. Paraneoplastic cerebellar degeneration , 2004, Journal of Neuro-Oncology.
[2] P. Wen,et al. Neurologic Complications of Cancer , 2003 .
[3] H. Liebman,et al. Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab) , 2002, Annals of the rheumatic diseases.
[4] M. J. van den Bent,et al. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy , 2002, Journal of Neurology.
[5] J. Honnorat,et al. Oligoclonal T-cells in blood and target tissues of patients with anti-Hu syndrome , 2002, Journal of Neuroimmunology.
[6] L. Kappos,et al. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. , 2002, Journal of neurology.
[7] G. Escaramís,et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. , 2001, Brain : a journal of neurology.
[8] P. Itin,et al. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: Report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL , 2001, American journal of hematology.
[9] M. Baccarani,et al. Rituximab for myasthenia gravis developing after bone marrow transplant , 2000, Neurology.
[10] J. Dalmau,et al. Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies , 2000, Neurology.
[11] J. Honnorat,et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone , 2000, Journal of neurology, neurosurgery, and psychiatry.
[12] S. Nakanishi,et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. , 2000, The New England journal of medicine.
[13] R. Darnell,et al. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration , 2000, Annals of neurology.
[14] J. Honnorat,et al. Ulip/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromes , 1999, The European journal of neuroscience.
[15] J. Gligorov,et al. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. , 1999, The New England journal of medicine.
[16] J. Molinuevo,et al. Clinical outcome of patients with anti-Hu–associated encephalomyelitis after treatment of the tumor , 1999, Neurology.
[17] A. Pestronk,et al. IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab , 1999, Neurology.
[18] J. Dalmau,et al. Cell‐mediated autoimmunity in paraneoplastic neurological syndromes with anti‐Hu antibodies , 1999, Annals of neurology.
[19] S. Gultekin,et al. Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. , 1999, Brain : a journal of neurology.
[20] B. Cohen,et al. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. , 1998, Blood.
[21] P. S. Sillevis Smitt,et al. Anti-Ri positive opsoclonus-myoclonus-ataxia in ovarian duct cancer , 1998, Journal of Neurology.
[22] S. Gultekin,et al. Localization of the neuronal antigen recognized by anti-Tr antibodies from patients with paraneoplastic cerebellar degeneration and Hodgkin’s disease in the rat nervous system , 1998, Acta Neuropathologica.
[23] J. Honnorat,et al. POP66, A Paraneoplastic Encephalomyelitis-related Antigen, Is a Marker of Adult Oligodendrocytes , 1998, Journal of neuropathology and experimental neurology.
[24] W. Mason,et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. , 1997, Brain : a journal of neurology.
[25] I. Ferrer,et al. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease , 1997, Journal of Neuroimmunology.
[26] I Royston,et al. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. , 1997, Blood.
[27] J. Honnorat,et al. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[28] L. Wilkins. Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice , 1995 .
[29] J. Dalmau,et al. Hu antigens: Reactivity with hu antibodies, tumor expression, and major immunogenic sites , 1995, Annals of neurology.
[30] T. Tedder,et al. CD20: a regulator of cell-cycle progression of B lymphocytes. , 1994, Immunology today.
[31] D. Czerwinski,et al. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. , 1994, Blood.
[32] S. Henzen‐Logmans,et al. Antineuronal antibodies in patients with neurologic complicat'lons of primary Sjögren's syndrome , 1993, Neurology.
[33] P. De Camilli,et al. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer , 1993, The Journal of experimental medicine.
[34] R. Darnell,et al. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system , 1993, Neuron.
[35] R. Darnell,et al. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies , 1993, The Lancet.
[36] L. Kline,et al. Antineuronal (anti‐Ri) antibodies in a patient with steroid‐responsive opsoclonus‐myoclonus , 1993, Neurology.
[37] R. Burd,et al. Spontaneous regression of small cell carcinoma of lung associated with severe neuropathy. , 1993, Cancer investigation.
[38] E. Tolosa,et al. Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. , 1993, Neurology.
[39] M. Rosenblum,et al. Paraneoplastic cerebellar degeneration. , 1992, Neurology.
[40] M. Rosenblum,et al. Anti‐Hu-Associated Paraneoplastic Encephalomyelitis/Sensory Neuronopathy A Clinical Study of 71 Patients , 1992, Medicine.
[41] I. Illa,et al. Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model , 1991, Journal of the Neurological Sciences.
[42] J. Henson,et al. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and sex-lethal , 1991, Cell.
[43] J. Posner,et al. Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[44] M. Rosenblum,et al. Anti‐Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer , 1991, Annals of neurology.
[45] B. O'neill,et al. Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies. , 1990, Mayo Clinic proceedings.
[46] H. Rothman,et al. Epidemiology of Hodgkin's disease , 1989, The Journal of the American Osteopathic Association.
[47] J. Trotter,et al. Cerebellar degeneration with Hodgkin disease. An immunological study. , 1976, Archives of neurology.
[48] H. Studer. [Paraneoplastic syndromes]. , 1973, Schweizerische medizinische Wochenschrift.
[49] R. Wyburn-Mason. Cancer and the Nervous System , 1969 .
[50] R. Layzer. Cancer and the nervous system. , 1969, California medicine.
[51] P. Buxton,et al. Cerebellar degeneration with Hodgkin's disease. , 1966, Journal of neurology, neurosurgery, and psychiatry.